ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says

November 25, 1977

Patients Prefer Silicone Over Saline Implants

November 26, 2010

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

November 6, 1981

ACS President Huerta Disagrees With Staff On Cell Phone Danger.

August 1, 2008